Aspartame: Scientific Evaluation in the Postmarketing Period

Publisher： Elsevier

ISSN： 0273-2300

Source： Regulatory Toxicology and Pharmacology, Vol.34, Iss.3, 2001-12, pp. : 221-233

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medical Records-Based Postmarketing Safety Evaluation of Rare Events with Uncertain Status

By Cao Hongyuan LaVange Lisa M. Heyse Joseph F. Mast T. Christopher Kosorok Michael R.

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 1, 2013-01 ,pp. : 201-212

Taylor & Francis Ltd

Access to resources Recommend Favorite

Medical Records-Based Postmarketing Safety Evaluation of Rare Events with Uncertain Status

By Cao Hongyuan LaVange Lisa M. Heyse Joseph F. Mast T. Christopher Kosorok Michael R.

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 4, 2013-07 ,pp. : 744-755

Taylor & Francis Ltd

Access to resources Recommend Favorite

Evaluation of the Efficacy and Tolerability of Acarbose in Patients with Diabetes Mellitus: A Postmarketing Surveillance Study

By Spengler M. Schmitz H. Landen H.

Clinical Drug Investigation, Vol. 25, Iss. 10, 2005-01 ,pp. : 651-659

Adis International

Access to resources Recommend Favorite

Evaluation of Reporting Bias in Postmarketing Risk Assessment Based on Spontaneous Reporting Systems

By Alemayehu Demissie

Pharmaceutical Medicine, Vol. 23, Iss. 4, 2009-08 ,pp. : 195-200

Adis International

Access to resources Recommend Favorite

Risk Management Strategies in the Postmarketing Period: Safety Experience with the US and European Bosentan Surveillance Programmes

By Segal Eleanor S. Valette Cecile Oster Laurence Bouley Luc Edfjall Catarina Herrmann Peter Raineri Massimo Kempff Mary Beacham Saundra Cinda van Lierop

Drug Safety, Vol. 28, Iss. 11, 2005-01 ,pp. : 971-980

Adis International

Access to resources Recommend Favorite